SCHEDULE 13G/A · 2026-10-28
Bank of America Corp updates its ownership stake in Research Alliance Corp III, reflecting ongoing activity in the pharmaceutical preparations sector.
| Name | Research Alliance Corp III |
|---|---|
| CIK | 0002118032 |
| Tickers | RACC |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 981918931 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | E9 Cayman Islands |
| Phone | (617) 778-2500 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Bank of America Corp updates its ownership stake in Research Alliance Corp III, reflecting ongoing activity in the pharmaceutical preparations sector.
51 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-128735 | 005-95731 | 261563834 | 34 | 11073 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-463814 | 005-95731 | 261562685 | 34 | 10173 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001493152-26-052395 | 005-95731 | 261561123 | 34 | 11715 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-005054 | 005-95731 | 261555122 | 34 | 15024 | |||
| 2026-11-16 | 10-Q | 10-Q | 0001193125-26-461340 | 001-43302 | 261554843 | 34 | 3895985 | 1 | 1 | |
| 2026-11-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001011438-26-000689 | 005-95731 | 261552437 | 34 | 17265 | |||
| 2026-11-04 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-003436 | 333-298537 | 261524408 | 33 | 2703 | ||
| 2026-11-04 | 424B4 | 424B4 | 0001193125-26-447320 | 333-298537 | 261522558 | 33 | 7229953 | |||
| 2026-10-30 | S-4/A | S-4/A | 0001193125-26-441817 | 333-298537 | 261508746 | 33 | 17592576 | 1 | 1 | |
| 2026-10-28 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000070858-26-000533 | 005-95731 | 261495003 | 34 | 171227 | |||
| 2026-10-07 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-114377 | 005-95731 | 261447353 | 34 | 1193431 | |||
| 2026-09-28 | S-4/A | S-4/A | 0001193125-26-403078 | 333-298537 | 261411607 | 33 | 16775497 | 1 | 1 | |
| 2026-09-16 | 425 | 425 | 0001193125-26-392963 | 001-43302 | 261383468 | 34 | 4102181 | |||
| 2026-09-11 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-004339 | 005-95731 | 261374279 | 34 | 12756 | |||
| 2026-09-11 | 425 | 425 | 0001193125-26-388359 | 001-43302 | 261372567 | 34 | 813421 | |||
| 2026-08-24 | S-4 | S-4 | 0001193125-26-363800 | 333-298537 | 261311669 | 33 | 17375214 | 1 | 1 | |
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-097423 | 005-95731 | 261284494 | 34 | 15201 | |||
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-352319 | 005-95731 | 261281954 | 34 | 123901 | |||
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-003434 | 005-95731 | 261275843 | 34 | 14894 | |||
| 2026-08-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000902664-26-003433 | 005-95731 | 261270195 | 34 | 16200 | |||
| 2026-08-12 | 10-Q | 10-Q | 0001193125-26-346912 | 001-43302 | 261267801 | 34 | 3573270 | 1 | 1 | |
| 2026-08-05 | 425 | 425 | 0001193125-26-335338 | 001-43302 | 261244382 | 34 | 183437 | |||
| 2026-08-03 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000070858-26-000405 | 005-95731 | 261233322 | 34 | 171175 | |||
| 2026-07-29 | 425 | 425 | 0001193125-26-321743 | 001-43302 | 261213641 | 34 | 406844 | |||
| 2026-07-28 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0002135648-26-000011 | 005-95731 | 261212050 | 34 | 26941 | |||
| 2026-07-28 | 425 | 425 | 0001193125-26-318558 | 001-43302 | 261207247 | 34 | 1178290 | |||
| 2026-07-27 | 425 | 425 | 0001193125-26-316960 | 001-43302 | 261202900 | 34 | 14591529 | |||
| 2026-07-27 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001193125-26-316954 | 001-43302 | 261202896 | 34 | 15146201 | 1 | 1 |
| 2026-07-02 | 10-Q | 10-Q | 0001193125-26-294451 | 001-43302 | 261150860 | 34 | 2494444 | 1 | 1 | |
| 2026-05-29 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000921895-26-001505 | 005-95731 | 261046448 | 34 | 38361 | |||
| 2026-05-29 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0002135648-26-000008 | 005-95731 | 261046311 | 34 | 24327 | |||
| 2026-05-29 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001493152-26-026372 | 005-95731 | 261044623 | 34 | 23049 | |||
| 2026-05-28 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-245567 | 001-43302 | 261038000 | 34 | 101577 | ||
| 2026-05-28 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001831942-26-000026 | 005-95731 | 261036188 | 34 | 15026 | |||
| 2026-05-28 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-245154 | 005-95731 | 261035336 | 34 | 772238 | |||
| 2026-05-21 | 4 | xslF345X06/form4-05212026_080548.xml | 0002135648-26-000003 | 5098 | ||||||
| 2026-05-21 | 4 | xslF345X06/form4-05212026_080516.xml | 0001817056-26-000003 | 5282 | ||||||
| 2026-05-21 | 8-K | 8-K | 1.01,3.02,5.02,5.03,8.01,9.01 | 0001193125-26-234382 | 001-43302 | 261008238 | 34 | 935810 | ||
| 2026-05-20 | 424B4 | 424B4 | 0001193125-26-232525 | 333-294549 | 261003856 | 33 | 1526555 | |||
| 2026-05-19 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001699 | 333-294549 | 261001262 | 33 | 1732 | ||
| 2026-05-19 | 3 | xslF345X06/form3-05192026_080547.xml | 0002135648-26-000002 | 5241 | ||||||
| 2026-05-19 | 3 | xslF345X06/form3-05192026_080519.xml | 0001817056-26-000002 | 10532 | ||||||
| 2026-05-19 | 3 | xslF345X06/form3-05192026_080513.xml | 0001692659-26-000005 | 9986 | ||||||
| 2026-05-19 | 3 | xslF345X06/form3-05192026_080526.xml | 0002124312-26-000002 | 8380 | ||||||
| 2026-05-19 | 3 | xslF345X06/form3-05192026_080519.xml | 0001383731-26-000008 | 10045 | ||||||
| 2026-05-19 | 3 | xslF345X06/form3-05192026_080543.xml | 0002133304-26-000003 | 8448 | ||||||
| 2026-05-18 | CERT | 8A_CERT_RACC_0002118032.pdf | 0001354457-26-000474 | 001-43302 | 26992727 | 34 | 180256 | |||
| 2026-05-18 | 8-A12B | 8-A12B | 0001193125-26-228664 | 001-43302 | 26992047 | 34 | 12850 | |||
| 2026-05-13 | S-1/A | S-1/A | 0001193125-26-220331 | 333-294549 | 26970654 | 33 | 4562955 | 1 | 1 | |
| 2026-04-23 | S-1/A | S-1/A | 0001193125-26-173973 | 333-294549 | 26889567 | 33 | 4612298 | 1 | 1 | |
| 2026-03-24 | S-1 | S-1 | 0001193125-26-120705 | 333-294549 | 26784180 | 33 | 3931065 | 1 | 1 |
One latest value per concept from companyfacts (61 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ffd | NetFeeAmt | NetFeeAmt | USD | 31,475.5 | 2026-08-24 | S-4 | 2026-08-24 | 0001193125-26-363800 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 31,475.5 | 2026-08-24 | S-4 | 2026-08-24 | 0001193125-26-363800 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 227.92M | 2026-08-24 | S-4 | 2026-08-24 | 0001193125-26-363800 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-08-24 | S-4 | 2026-08-24 | 0001193125-26-363800 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-08-24 | S-4 | 2026-08-24 | 0001193125-26-363800 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 52,276 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 331,035 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | Assets | Assets | USD | 78.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 312,054 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 75.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 75.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | Cash | Cash | USD | 183,405 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 183,405 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 183,405 | 2026-02-19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 |
| us-gaap | CashFDICInsuredAmount | Cash, FDIC Insured Amount | USD | 250,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | DebtInstrumentConvertibleConversionPrice1 | Debt Instrument, Convertible, Conversion Price | USD/shares | 10 | 2026-11-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | DeferredCosts | Deferred Costs, Noncurrent | USD | 128,033 | 2026-02-25 | S-4 | 2026-08-24 | 0001193125-26-363800 | |||
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.18 | 2026-02-19 | 2026-02-25 | S-4 | 2026-08-24 | 0001193125-26-363800 | ||
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.18 | 2026-02-19 | 2026-02-25 | S-4 | 2026-08-24 | 0001193125-26-363800 | ||
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 1.23M | 2026-02-19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | 383,311 | 2026-02-19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 8,697 | 2026-02-19 | 2026-02-25 | S-4 | 2026-08-24 | 0001193125-26-363800 | ||
| us-gaap | IncreaseDecreaseInOtherCurrentAssets | Increase (Decrease) in Other Current Assets | USD | 2,600 | 2026-02-19 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-07-02 | 0001193125-26-294451 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | 203,695 | 2026-02-19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 953,273 | 2026-02-19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 |
| us-gaap | Liabilities | Liabilities | USD | 6.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 78.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 2.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 76.23M | 2026-02-19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -75.00M | 2026-02-19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -1.05M | 2026-02-19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -1.96M | 2026-02-19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -734,126 | 2026-02-19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 |
| us-gaap | NotesPayableCurrent | Notes Payable, Current | USD | 300,000 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-07-02 | 0001193125-26-294451 | |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-02-19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -1.23M | 2026-02-19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 2,600 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-07-02 | 0001193125-26-294451 | |
| us-gaap | OtherIncome | Other Income | USD | 238,468 | 2026-02-19 | 2026-06-30 | S-4 | 2026-08-24 | 0001193125-26-363800 | ||
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 1.54M | 2026-02-19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 |
| us-gaap | PaymentsToInvestInDecommissioningFund | Payments to Acquire Investments to be Held in Decommissioning Trust Fund | USD | 75.00M | 2026-02-19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 1.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 128,649 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | PrepaidExpenseNoncurrent | Prepaid Expense, Noncurrent | USD | 75,046 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 75.00M | 2026-02-19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 25,000 | 2026-02-19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 2.75M | 2026-02-19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 |
| us-gaap | ProceedsFromNotesPayable | Proceeds from Notes Payable | USD | 300,000 | 2026-02-19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | 300,000 | 2026-02-19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -3.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 0 | 2026-02-19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | -3.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 25,000 | 2026-02-19 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 |
| us-gaap | TemporaryEquityIssuePeriodIncreaseOrDecrease | Temporary Equity, Carrying Amount, Period Increase (Decrease) | USD | 4.72M | 2026-02-19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 |
| us-gaap | TemporaryEquityValueExcludingAdditionalPaidInCapital | Temporary Equity, Par Value | USD | 75.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-461340 | |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 189,076 | 2026-02-19 | 2026-02-25 | S-4 | 2026-08-24 | 0001193125-26-363800 | ||
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 189,076 | 2026-02-19 | 2026-02-25 | S-4 | 2026-08-24 | 0001193125-26-363800 |